RP 59500

Known as: RP-59500 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2000
051019912000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
The pharmacology, pharmacokinetics, activity, and potential clinical role of quinupristin-dalfopristin (RP 59500) are described… (More)
Is this relevant?
1996
1996
Previous time-kill studies have shown that RP 59500 is rapidly bactericidal against pneumococci. To extend these findings, the… (More)
Is this relevant?
1995
1995
The activity of RP 59500 (quinupristin/dalfopristin) was evaluated in vitro against antibiotic-resistant strains of Streptococcus… (More)
Is this relevant?
1992
1992
The in-vitro activity of RP 59500 was compared with that of other appropriate antibiotics against 131 staphylococci, 97… (More)
Is this relevant?
1992
1992
A study of the in-vitro activity of RP 59500, a semisynthetic derivative of pristinamycin, against a range of Gram-positive… (More)
Is this relevant?
1992
1992
RP 59500 is a semisynthetic streptogramin (Sg) composed of two synergic components: RP 57669 and RP 54476. The activities of RP… (More)
Is this relevant?
1992
1992
RP 59500 is a new semisynthetic injectable streptogramin antibiotic composed of two compounds which interact synergically, RP… (More)
Is this relevant?
1992
1992
The in-vitro activity of RP 59500, an injectable streptogramin derived from pristinamycin, was determined by agar dilution and… (More)
Is this relevant?
1992
1992
The activity of RP 59500 against Gram-positive cocci was determined by an agar dilution method and compared with that of… (More)
Is this relevant?
1991
1991
The in vitro activity of RP 59500, a semisynthetic pristinamycin, was compared with the activities of vancomycin, oxacillin… (More)
Is this relevant?